Copyright Reports & Markets. All rights reserved.

Global Recombinant Human Follicle Stimulating Hormone Injection Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Recombinant Human Follicle Stimulating Hormone Injection by Type
    • 1.3.1 Overview: Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Recombinant Human Follicle Stimulating Hormone Injection Consumption Value Market Share by Type in 2025
    • 1.3.3 75IU
    • 1.3.4 150IU
    • 1.3.5 300IU
    • 1.3.6 Others
  • 1.4 Global Recombinant Human Follicle Stimulating Hormone Injection Market by Application
    • 1.4.1 Overview: Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Women
    • 1.4.3 Men
  • 1.5 Global Recombinant Human Follicle Stimulating Hormone Injection Market Size & Forecast
  • 1.6 Global Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast by Region
    • 1.6.1 Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region, (2021-2032)
    • 1.6.3 North America Recombinant Human Follicle Stimulating Hormone Injection Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size and Prospect (2021-2032)
    • 1.6.6 South America Recombinant Human Follicle Stimulating Hormone Injection Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Merck KGaA
    • 2.1.1 Merck KGaA Details
    • 2.1.2 Merck KGaA Major Business
    • 2.1.3 Merck KGaA Recombinant Human Follicle Stimulating Hormone Injection Product and Solutions
    • 2.1.4 Merck KGaA Recombinant Human Follicle Stimulating Hormone Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck KGaA Recent Developments and Future Plans
  • 2.2 Organon
    • 2.2.1 Organon Details
    • 2.2.2 Organon Major Business
    • 2.2.3 Organon Recombinant Human Follicle Stimulating Hormone Injection Product and Solutions
    • 2.2.4 Organon Recombinant Human Follicle Stimulating Hormone Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Organon Recent Developments and Future Plans
  • 2.3 Gedeon Richter
    • 2.3.1 Gedeon Richter Details
    • 2.3.2 Gedeon Richter Major Business
    • 2.3.3 Gedeon Richter Recombinant Human Follicle Stimulating Hormone Injection Product and Solutions
    • 2.3.4 Gedeon Richter Recombinant Human Follicle Stimulating Hormone Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Gedeon Richter Recent Developments and Future Plans
  • 2.4 Ferring
    • 2.4.1 Ferring Details
    • 2.4.2 Ferring Major Business
    • 2.4.3 Ferring Recombinant Human Follicle Stimulating Hormone Injection Product and Solutions
    • 2.4.4 Ferring Recombinant Human Follicle Stimulating Hormone Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Ferring Recent Developments and Future Plans
  • 2.5 Changchun High-Tech
    • 2.5.1 Changchun High-Tech Details
    • 2.5.2 Changchun High-Tech Major Business
    • 2.5.3 Changchun High-Tech Recombinant Human Follicle Stimulating Hormone Injection Product and Solutions
    • 2.5.4 Changchun High-Tech Recombinant Human Follicle Stimulating Hormone Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Changchun High-Tech Recent Developments and Future Plans
  • 2.6 Theramex
    • 2.6.1 Theramex Details
    • 2.6.2 Theramex Major Business
    • 2.6.3 Theramex Recombinant Human Follicle Stimulating Hormone Injection Product and Solutions
    • 2.6.4 Theramex Recombinant Human Follicle Stimulating Hormone Injection Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Theramex Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Recombinant Human Follicle Stimulating Hormone Injection Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Recombinant Human Follicle Stimulating Hormone Injection by Company Revenue
    • 3.2.2 Top 3 Recombinant Human Follicle Stimulating Hormone Injection Players Market Share in 2025
    • 3.2.3 Top 6 Recombinant Human Follicle Stimulating Hormone Injection Players Market Share in 2025
  • 3.3 Recombinant Human Follicle Stimulating Hormone Injection Market: Overall Company Footprint Analysis
    • 3.3.1 Recombinant Human Follicle Stimulating Hormone Injection Market: Region Footprint
    • 3.3.2 Recombinant Human Follicle Stimulating Hormone Injection Market: Company Product Type Footprint
    • 3.3.3 Recombinant Human Follicle Stimulating Hormone Injection Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Recombinant Human Follicle Stimulating Hormone Injection Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Recombinant Human Follicle Stimulating Hormone Injection Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Recombinant Human Follicle Stimulating Hormone Injection Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Recombinant Human Follicle Stimulating Hormone Injection Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Type (2021-2032)
  • 6.2 North America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Application (2021-2032)
  • 6.3 North America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country
    • 6.3.1 North America Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Country (2021-2032)
    • 6.3.2 United States Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Type (2021-2032)
  • 7.2 Europe Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Application (2021-2032)
  • 7.3 Europe Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country
    • 7.3.1 Europe Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 7.3.3 France Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Market Size by Region
    • 8.3.1 Asia-Pacific Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Region (2021-2032)
    • 8.3.2 China Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 8.3.5 India Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Type (2021-2032)
  • 9.2 South America Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Application (2021-2032)
  • 9.3 South America Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country
    • 9.3.1 South America Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Market Size by Country
    • 10.3.1 Middle East & Africa Recombinant Human Follicle Stimulating Hormone Injection Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Recombinant Human Follicle Stimulating Hormone Injection Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Recombinant Human Follicle Stimulating Hormone Injection Market Drivers
  • 11.2 Recombinant Human Follicle Stimulating Hormone Injection Market Restraints
  • 11.3 Recombinant Human Follicle Stimulating Hormone Injection Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Recombinant Human Follicle Stimulating Hormone Injection Industry Chain
  • 12.2 Recombinant Human Follicle Stimulating Hormone Injection Upstream Analysis
  • 12.3 Recombinant Human Follicle Stimulating Hormone Injection Midstream Analysis
  • 12.4 Recombinant Human Follicle Stimulating Hormone Injection Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Recombinant Human Follicle Stimulating Hormone Injection market size was valued at US$ 1420 million in 2025 and is forecast to a readjusted size of US$ 2014 million by 2032 with a CAGR of 5.2% during review period.
    Recombinant follicle stimulating hormone is used in the treatment of female infertility and male hypogonadism. It is used in women who have a problem in ovulation or are undergoing fertility treatment like in-vitro fertilization. In men, it helps in the production of sperm cells.
    Infertility affects many people at some point in their lives, according to a new report from the World Health Organization (WHO) released in 2023. About 17.5% of adults (about one in six people worldwide) experience infertility, highlighting the urgent need to expand access to affordable, high-quality reproductive health care for those who need it. Recombinant human follicle stimulating hormone is used in the treatment of female infertility and male hypogonadism. The safety and effectiveness of recombinant human follicle stimulating hormone have been verified in a large number of clinical applications. In the future, as biosimilar technology continues to mature and costs decrease, generic drugs will gradually break the market monopoly of original drugs and improve the accessibility of treatment. Generic drug companies will further enhance their market competitiveness by optimizing production processes, improving product quality and developing long-acting preparations.
    This report is a detailed and comprehensive analysis for global Recombinant Human Follicle Stimulating Hormone Injection market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Recombinant Human Follicle Stimulating Hormone Injection market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Recombinant Human Follicle Stimulating Hormone Injection market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Recombinant Human Follicle Stimulating Hormone Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Recombinant Human Follicle Stimulating Hormone Injection market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Recombinant Human Follicle Stimulating Hormone Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Recombinant Human Follicle Stimulating Hormone Injection market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Organon, Gedeon Richter, Ferring, Changchun High-Tech, Theramex, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Recombinant Human Follicle Stimulating Hormone Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    75IU
    150IU
    300IU
    Others
    Market segment by Application
    Women
    Men
    Market segment by players, this report covers
    Merck KGaA
    Organon
    Gedeon Richter
    Ferring
    Changchun High-Tech
    Theramex
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Recombinant Human Follicle Stimulating Hormone Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Recombinant Human Follicle Stimulating Hormone Injection, with revenue, gross margin, and global market share of Recombinant Human Follicle Stimulating Hormone Injection from 2021 to 2026.
    Chapter 3, the Recombinant Human Follicle Stimulating Hormone Injection competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Recombinant Human Follicle Stimulating Hormone Injection market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Recombinant Human Follicle Stimulating Hormone Injection.
    Chapter 13, to describe Recombinant Human Follicle Stimulating Hormone Injection research findings and conclusion.

    Buy now